GLP-1 Receptor Agonist
A class of drugs that bind to and activate the GLP-1 receptor, mimicking the effects of native GLP-1. Includes semaglutide, liraglutide, and dulaglutide.
What does GLP-1 Receptor Agonist mean in peptide research?
A class of drugs that bind to and activate the GLP-1 receptor, mimicking the effects of native GLP-1. Includes semaglutide, liraglutide, and dulaglutide. This term is part of the broader field of peptide research, which encompasses both FDA-approved therapeutic peptides and research-grade compounds used in scientific investigation.
Why this term matters
Understanding GLP-1 Receptor Agonist is foundational for anyone reviewing peptide research literature, comparing different research compounds, or following regulatory developments in this field. The term appears across pharmacology textbooks, FDA documentation, and clinical trial reports.
Where to learn more
For deeper context, see our peptide research articles: